Search Orphan Drug Designations and Approvals
-
Generic Name: | Interferon beta-1a (recombinant) |
---|---|
Date Designated: | 12/02/1992 |
Orphan Designation: | Treatment of symptomatic patients with AIDS including all patients with CD4 T-cell counts less than 200 cells per mm3. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 12/21/2017 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
EMD Serono, Inc. One Technology Place Rockland, Massachusetts 02370 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-